← SynDRA
LATRUNCULIN B
SynDRA canonical compound SYN0008976 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | ACTA1 | MKL1 | SPIRE2 |
| Mechanism of action | actin polymerization inhibitor |
All known targets
Mechanisms of action (all sources)
- actin polymerization inhibitor
Cross-references
Synonyms
- INS-115644
- Cytoskeleton-targeting compounds (glaucoma), Wisconsin Alumni Research Foundation (WARF)/Inspire
- Lat B
- (+)-latrunculin B
- LW7U308U7U
- CHEBI:49703
- NSC 339663
- INS115644
- RefChem:152464
- DTXCID201022649
- UNII-LW7U308U7U
- NSC339663
- NSHPHXHGRHSMIK-JRIKCGFMSA-N
- LATRUNCULIN B [MI]
- BSPBio_001189
- SCHEMBL2531366
- BCBcMAP01_000226
- HMS1362K11
- HMS1792K11
- HMS1990K11
- HMS3403K11
- BDA34394
- LAT-B; NSC 339663
- BDBM50508923
- MFCD00270879
- AKOS032947159
- IDI1_002180
- SMP2_000317
- NCGC00163459-03
- AS-83262
- DA-49463
- HY-101848
- CS-0022006
- T20636
- F951487
- BRD-K30455030-001-03-3
- BRD-K61292460-001-02-3
- Latrunculin B from Latruncula magnifica, >=80% (HPLC), solid
Look up LATRUNCULIN B in the interactive SynDRA portal →